EGFR and central nervous system cancer: This analysis demonstrated that gliomas with 1p19q codeletion in comparison to gliomas with EGFR amplification were significantly enriched in the "proneural" gene set associated with good prognosis reported by Phillips et al. and in the good prognosis neurogenesis-related gene set reported by Freije et al. (HC1A gene set) [5,28].